Fibroblast growth factor 2 enhances striatal and nigral neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
- 15 May 2008
- journal article
- Published by Elsevier in Neuroscience
- Vol. 153 (3) , 664-670
- https://doi.org/10.1016/j.neuroscience.2008.02.063
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Iron and Paraquat as Synergistic Environmental Risk Factors in Sporadic Parkinson's Disease Accelerate Age-Related NeurodegenerationJournal of Neuroscience, 2007
- Protocol for the MPTP mouse model of Parkinson's diseaseNature Protocols, 2007
- Intrastriatal Transforming Growth Factor α Delivery to a Model of Parkinson's Disease Induces Proliferation and Migration of Endogenous Adult Neural Progenitor Cells without Differentiation into Dopaminergic NeuronsJournal of Neuroscience, 2004
- Neuronal replacement from endogenous precursors in the adult brain after strokeNature Medicine, 2002
- Stem cell factor stimulates neurogenesis in vitro and in vivoJournal of Clinical Investigation, 2002
- Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesisNeuroscience, 2001
- Parkinson's DiseaseNew England Journal of Medicine, 1998
- A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brainBrain Research, 1995
- Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to agingBrain Research, 1993
- Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's diseaseNeurology, 1993